Frontlight ResearchEarly access
Trial site
Texas Clinical Research Institute
- 6running trials
- 3closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Fatty liver disease (MASLD/MASH)6 trials
- Liver cirrhosis2 trials
- Obesity1 trial
- Primary biliary cholangitis1 trial
- Type 2 diabetes1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 24 trials
- Phase 34 trials
- Phase 41 trial
- Status
- Active, not recruiting4 trials
- Completed3 trials
- Not yet recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Madrigal Pharmaceuticals, Inc.2 trials
- Pfizer2 trials
- Gilead Sciences1 trial
- Hanmi Pharmaceutical Company Limited1 trial
- HighTide Therapeutics (Hong Kong) Limited1 trial
- and 2 more
Running trials
Recruiting
Active, not recruiting
Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus
Recruiting
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Active, not recruiting
Active, not recruiting
Active, not recruiting
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Fatty liver disease (MASLD/MASH)1 recruiting
- Primary biliary cholangitis1 recruiting
Closed trials
Completed
Completed
Completed
Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)
Site data: ClinicalTrials.govUpdated 12 Nov 2026